Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,629 | 61,580 | 9,238 | 20,993 | 55,890 |
| Marketable Securities | 114,108 | 165,336 | N/A | 22,764 | N/A |
| Receivables | 6 | 116 | 1,165 | 7,472 | 1,608 |
| Inventories | N/A | N/A | N/A | N/A | 1,396 |
| Other current assets | 0 | 0 | 5,301 | 1,543 | 0 |
| TOTAL | $148,389 | $231,160 | $16,837 | $53,215 | $59,329 |
| Non-Current Assets | |||||
| PPE Net | 76,597 | 57,321 | 5,576 | 371 | 1,976 |
| Intangibles | 40,000 | 50,000 | 74,062 | 0 | 0 |
| Other Non-Current Assets | 1,986 | 2,620 | 1,416 | 4,505 | 3,134 |
| TOTAL | $118,583 | $109,941 | $81,054 | $4,876 | $5,110 |
| Total Assets | $266,972 | $341,101 | $97,891 | $58,091 | $64,439 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,511 | 10,343 | 6,909 | 1,541 | 966 |
| Accrued Expenses | 7,489 | 5,478 | 3,588 | 1,301 | 1,032 |
| Other current liabilities | N/A | N/A | 5,072 | 276 | N/A |
| TOTAL | $28,679 | $18,230 | $15,664 | $3,118 | $2,266 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,569 | 1,625 | 1,676 | N/A | N/A |
| Deferred Revenues | N/A | 1,400 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,391 | 1,483 | 780 | 331 | 896 |
| TOTAL | $31,262 | $32,203 | $7,048 | $331 | $896 |
| Total Liabilities | $59,941 | $50,433 | $22,712 | $3,449 | $3,162 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,933 | 74,052 | 58,692 | N/A | N/A |
| Common Shares | 74 | 70 | 28 | 142 | 142 |
| Retained earnings | -334,840 | -231,719 | -152,440 | -105,932 | -98,597 |
| Other shareholders' equity | 110 | -51 | 0 | 0 | 0 |
| TOTAL | $207,031 | $290,668 | $75,179 | $54,642 | $61,277 |
| Total Liabilities And Equity | $266,972 | $341,101 | $97,891 | $58,091 | $64,439 |